Sattva S Neelapu


  • 6415 Citations
  • 42 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sattva S Neelapu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 46 Similar Profiles
Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Follicular Lymphoma
Disease-Free Survival

A pilot study of pembrolizumab in smoldering myeloma: Report of the clinical, immune, and genomic analysis

Manasanch, E. E., Han, G., Mathur, R., Qing, Y., Zhang, Z., Lee, H. C., Weber, D. M., Amini, B., Berkova, Z., Eterovic, K., Zhang, S., Zhang, J., Song, X., Mao, X., Morgan, M., Feng, L., Baladandayuthapani, V., Futreal, A., Wang, L., Neelapu, S. S. & 1 others, Orlowski, R., Jan 1 2019, In : Blood Advances. 3, 15, p. 2400-2408 9 p.

Research output: Contribution to journalArticle

Open Access
Bone Marrow
Interstitial Nephritis
Multiple Myeloma
39 Citations (Scopus)

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

Lee, D. W., Santomasso, B. D., Locke, F. L., Ghobadi, A., Turtle, C. J., Brudno, J. N., Maus, M. V., Park, J. H., Mead, E., Pavletic, S., Go, W. Y., Eldjerou, L., Gardner, R. A., Frey, N., Curran, K. J., Peggs, K., Pasquini, M., DiPersio, J. F., van den Brink, M. R. M., Komanduri, K. V. & 2 others, Grupp, S. A. & Neelapu, S. S., Apr 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 4, p. 625-638 14 p.

Research output: Contribution to journalReview article

Open Access
Neurotoxicity Syndromes
Nervous System
Antigen Receptors
Cell- and Tissue-Based Therapy

CAR-T efficacy: Is conditioning the key?

Neelapu, S. S., Apr 25 2019, In : Blood. 133, 17, p. 1799-1800 2 p.

Research output: Contribution to journalReview article

Open Access
CD19 Antigens
Antigen Receptors
Cell- and Tissue-Based Therapy
T-Cell Antigen Receptor
Non-Hodgkin's Lymphoma

Chimeric Antigen Receptor–Engineered T Cell Therapy in Lymphoma

Strati, P. & Neelapu, S. S., May 1 2019, In : Current oncology reports. 21, 5, 38.

Research output: Contribution to journalReview article

B-Cell Lymphoma
Cell- and Tissue-Based Therapy
T-Cell Antigen Receptor
Antigen Receptors